Professor Malcolm Finlay is a Consultant Cardiologist and Cardiac Electrophysiologist at Barts Heart Centre and OneWelbeck, London, and Honorary Professor at Queen Mary University of London. He specialises in atrial fibrillation and complex arrhythmias, combining high-volume clinical practice with medical technology innovation. Prof. Finlay co-founded Rhythm AI, Echopoint Medical, and Epicardio, developing FDA-cleared mapping, optical physiology, and cardiac simulation tools used globally. A pioneer in translational medicine, he introduced day-case atrial fibrillation ablation pathways and the first UK pulsed field ablation. His work bridges clinical care and engineering for safer, more effective heart treatments.